LEARNING OBJECTIVES
At the conclusion of our educational meeting, the participant will be able to:
- Acquaint with the new staging and pathology classification systems in lung cancer
- Recognize the clinical significance of molecular genotyping of lung cancer patients
- Understand the molecular pathways that hold promise for therapeutic intervention in lung cancer patients
- Update of Immunotherapy strategies for lung cancer
- Discuss the optimal methodology of evaluation of response in the era of translational research
- Recognize the importance of a multidisciplinary approach to the care of lung cancer patients
TOPICS
- Neuroendocrine lung cancer update
- Thymic cancer update
- Tumor heterogeneity
- Prognostic and predictive tumor markers
- Molecular signaling of LC
- NSCLC driver oncogenes
- Immunotherapy
- Evaluation of response
- Masterprotocols in lung cancer
- Agents related-toxicity management
- Newer generation TKIs inhibitors
Congress Secretariat
E.T.S. Events & Travel Solutions S.A.
154 El. Venizelou Str
N. Smyrni, Athens, Greece, 171 22
Tel.: +30 210 98 80 032
Fax.: +30 210 98 81 303
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: www.events.gr